Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study) - Mahaffey, K W; Neal, B; Perkovic, V (Circulation., 2018)
et al.